ROIV
Roivant Sciences Ltd. · Healthcare
President & Immunovant CEO Eric Venker sold $7.2M of Roivant Sciences Ltd.
Sold$7,153,393
$35.77Price
200,000Shares
−11%Stake
What ROIV did after the filing
- The stock from Wed, Sep 2 open, $34.64
- −1.7%
- S&P 500, same days
- +1.2%
Measured over 30 trading days, to the Oct 15 close.
Traded Fri, Aug 28. Filed Tue, Sep 1, 9:00 PM ET, after the close. Returns use the Sep 2 open and the Oct 15 close. Not investment advice.